Aggressive Systemic Mastocytosis — Trials

Aggressive Systemic Mastocytosis — Trials · CancerIndex

Clinical trials

Registered studies

9 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 100%
Top sponsor: Cogent Biosciences, Inc.
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–9 of 9 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04996875	(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis	recruiting	Phase 2	140	Cogent Biosciences, Inc.INDUSTRY	14	Sep 15, 2026	clinicaltrials
NCT05362773	A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies	active not recruiting	Phase 1	130	MacroGenicsINDUSTRY	1	Jul 28, 2026	clinicaltrials
NCT03580655